More than 30 speakers gathered at Cleveland Clinic’s one-day Cleveland Discovery and Innovation Forum, where Cleveland Clinic and IBM highlighted new progress using AI and quantum computing in biomedical research.
Five years into their Discovery Accelerator partnership, the two groups said it has backed more than 50 projects, produced multiple peer-reviewed publications and built training programs for a future advanced-computing workforce.
A featured research update showcased quantum modeling of a protein with more than 12,000 atoms, which organizers described as the largest protein structure known to be simulated on a quantum computer.
The event framed AI and quantum tools as increasingly relevant across disease prevention, early detection, treatment and personalized therapy, while also supporting Ohio’s broader research and innovation corridor.
Quantum AI is outperforming deep learning. What biological mystery will it solve next that classical computers can't?
With a star startup moving to Europe, is the US losing its edge in the quantum biotech race?
Beyond simulating molecules, when will quantum computers design a novel drug ready for human trials?
Cleveland Clinic–IBM Discovery Accelerator at Five Years: Quantum Computing and AI Drive Biomedical Breakthroughs
Overview
The third annual Cleveland Discovery and Innovation Forum, held on June 15, 2026, marked five years of progress in the Cleveland Clinic–IBM Discovery Accelerator partnership. This event brought together over 30 global leaders from academia, industry, and government, creating a rich environment for discussion and future planning. The partnership’s core mission is to harness artificial intelligence and quantum computing for groundbreaking biomedical research. At the forum, research announcements highlighted Cleveland Clinic’s steady progress in applying quantum computing to medicine, emphasizing a strong focus on advanced computational methods to accelerate discoveries and improve healthcare.